Influenza Virus Infection Induces a Narrow Antibody Response in Children but a Broad Recall Response in Adults

It is known since Thomas Francis, Jr. published his first paper on original antigenic sin in 1960 that the first infection(s) with influenza virus leaves a special immunological imprint which shapes immune responses to future infections with antigenically related influenza virus strains. Imprinting...

Full description

Saved in:
Bibliographic Details
Published inmBio Vol. 11; no. 1
Main Authors Meade, Philip, Kuan, Guillermina, Strohmeier, Shirin, Maier, Hannah E., Amanat, Fatima, Balmaseda, Angel, Ito, Kimihito, Kirkpatrick, Ericka, Javier, Andres, Gresh, Lionel, Nachbagauer, Raffael, Gordon, Aubree, Krammer, Florian
Format Journal Article
LanguageEnglish
Published United States American Society for Microbiology 21.01.2020
Subjects
Online AccessGet full text

Cover

Loading…
Abstract It is known since Thomas Francis, Jr. published his first paper on original antigenic sin in 1960 that the first infection(s) with influenza virus leaves a special immunological imprint which shapes immune responses to future infections with antigenically related influenza virus strains. Imprinting has been implicated in both protective effects as well as blunting of the immune response to vaccines. Despite the fact that this phenomenon was already described almost 60 years ago, we have very little detailed knowledge of the characteristics and breadth of the immune response to the first exposure(s) to influenza virus in life and how this compares to later exposure as adults. Here, we investigate these immune responses in detail using an influenza virus protein microarray. While our findings are mostly descriptive in nature and based on a small sample size, they provide a strong basis for future large-scale studies to better understand imprinting effects. In contrast to influenza virus vaccination, natural infection induces long-lived and relatively broad immune responses. However, many aspects of the antibody response to natural infection are not well understood. Here, we assessed the immune response after H1N1 influenza virus infection in children and adults in a Nicaraguan household transmission study using an influenza virus protein microarray (IVPM). This technology allows us to simultaneously measure IgG and IgA antibody responses to hemagglutinins of many different virus strains and subtypes quantitatively with a high throughput. We found that children under 6 years of age responded to natural infection with a relatively narrow response that targeted mostly the hemagglutinin of the strain that caused the infection. Adults, however, have a much broader response, including a boost in antibodies to many group 1 subtype hemagglutinins. Also, a strong recall response against historic H1 hemagglutinins that share the K133 epitope with the pandemic H1N1 virus was observed. Of note, some children, while responding narrowly within H1 and group 1 hemagglutinins, induced a boost to H3 and other group 2 hemagglutinins when infected with H1N1 when they had experienced an H3N2 infection earlier in life. This is an interesting phenomenon providing evidence for immune imprinting and a significant new insight which might be leveraged in future universal influenza virus vaccine strategies. Finally, preexisting immunity to pandemic H1 hemagglutinins was significantly associated with protection from infection in both children and adults. In adults, preexisting immunity to non-H1 group 1 hemagglutinins was also significantly associated with protection from infection. IMPORTANCE It is known since Thomas Francis, Jr. published his first paper on original antigenic sin in 1960 that the first infection(s) with influenza virus leaves a special immunological imprint which shapes immune responses to future infections with antigenically related influenza virus strains. Imprinting has been implicated in both protective effects as well as blunting of the immune response to vaccines. Despite the fact that this phenomenon was already described almost 60 years ago, we have very little detailed knowledge of the characteristics and breadth of the immune response to the first exposure(s) to influenza virus in life and how this compares to later exposure as adults. Here, we investigate these immune responses in detail using an influenza virus protein microarray. While our findings are mostly descriptive in nature and based on a small sample size, they provide a strong basis for future large-scale studies to better understand imprinting effects.
AbstractList ABSTRACT In contrast to influenza virus vaccination, natural infection induces long-lived and relatively broad immune responses. However, many aspects of the antibody response to natural infection are not well understood. Here, we assessed the immune response after H1N1 influenza virus infection in children and adults in a Nicaraguan household transmission study using an influenza virus protein microarray (IVPM). This technology allows us to simultaneously measure IgG and IgA antibody responses to hemagglutinins of many different virus strains and subtypes quantitatively with a high throughput. We found that children under 6 years of age responded to natural infection with a relatively narrow response that targeted mostly the hemagglutinin of the strain that caused the infection. Adults, however, have a much broader response, including a boost in antibodies to many group 1 subtype hemagglutinins. Also, a strong recall response against historic H1 hemagglutinins that share the K133 epitope with the pandemic H1N1 virus was observed. Of note, some children, while responding narrowly within H1 and group 1 hemagglutinins, induced a boost to H3 and other group 2 hemagglutinins when infected with H1N1 when they had experienced an H3N2 infection earlier in life. This is an interesting phenomenon providing evidence for immune imprinting and a significant new insight which might be leveraged in future universal influenza virus vaccine strategies. Finally, preexisting immunity to pandemic H1 hemagglutinins was significantly associated with protection from infection in both children and adults. In adults, preexisting immunity to non-H1 group 1 hemagglutinins was also significantly associated with protection from infection. IMPORTANCE It is known since Thomas Francis, Jr. published his first paper on original antigenic sin in 1960 that the first infection(s) with influenza virus leaves a special immunological imprint which shapes immune responses to future infections with antigenically related influenza virus strains. Imprinting has been implicated in both protective effects as well as blunting of the immune response to vaccines. Despite the fact that this phenomenon was already described almost 60 years ago, we have very little detailed knowledge of the characteristics and breadth of the immune response to the first exposure(s) to influenza virus in life and how this compares to later exposure as adults. Here, we investigate these immune responses in detail using an influenza virus protein microarray. While our findings are mostly descriptive in nature and based on a small sample size, they provide a strong basis for future large-scale studies to better understand imprinting effects.
In contrast to influenza virus vaccination, natural infection induces long-lived and relatively broad immune responses. However, many aspects of the antibody response to natural infection are not well understood. Here, we assessed the immune response after H1N1 influenza virus infection in children and adults in a Nicaraguan household transmission study using an influenza virus protein microarray (IVPM). This technology allows us to simultaneously measure IgG and IgA antibody responses to hemagglutinins of many different virus strains and subtypes quantitatively with a high throughput. We found that children under 6 years of age responded to natural infection with a relatively narrow response that targeted mostly the hemagglutinin of the strain that caused the infection. Adults, however, have a much broader response, including a boost in antibodies to many group 1 subtype hemagglutinins. Also, a strong recall response against historic H1 hemagglutinins that share the K133 epitope with the pandemic H1N1 virus was observed. Of note, some children, while responding narrowly within H1 and group 1 hemagglutinins, induced a boost to H3 and other group 2 hemagglutinins when infected with H1N1 when they had experienced an H3N2 infection earlier in life. This is an interesting phenomenon providing evidence for immune imprinting and a significant new insight which might be leveraged in future universal influenza virus vaccine strategies. Finally, preexisting immunity to pandemic H1 hemagglutinins was significantly associated with protection from infection in both children and adults. In adults, preexisting immunity to non-H1 group 1 hemagglutinins was also significantly associated with protection from infection.IMPORTANCE It is known since Thomas Francis, Jr. published his first paper on original antigenic sin in 1960 that the first infection(s) with influenza virus leaves a special immunological imprint which shapes immune responses to future infections with antigenically related influenza virus strains. Imprinting has been implicated in both protective effects as well as blunting of the immune response to vaccines. Despite the fact that this phenomenon was already described almost 60 years ago, we have very little detailed knowledge of the characteristics and breadth of the immune response to the first exposure(s) to influenza virus in life and how this compares to later exposure as adults. Here, we investigate these immune responses in detail using an influenza virus protein microarray. While our findings are mostly descriptive in nature and based on a small sample size, they provide a strong basis for future large-scale studies to better understand imprinting effects.In contrast to influenza virus vaccination, natural infection induces long-lived and relatively broad immune responses. However, many aspects of the antibody response to natural infection are not well understood. Here, we assessed the immune response after H1N1 influenza virus infection in children and adults in a Nicaraguan household transmission study using an influenza virus protein microarray (IVPM). This technology allows us to simultaneously measure IgG and IgA antibody responses to hemagglutinins of many different virus strains and subtypes quantitatively with a high throughput. We found that children under 6 years of age responded to natural infection with a relatively narrow response that targeted mostly the hemagglutinin of the strain that caused the infection. Adults, however, have a much broader response, including a boost in antibodies to many group 1 subtype hemagglutinins. Also, a strong recall response against historic H1 hemagglutinins that share the K133 epitope with the pandemic H1N1 virus was observed. Of note, some children, while responding narrowly within H1 and group 1 hemagglutinins, induced a boost to H3 and other group 2 hemagglutinins when infected with H1N1 when they had experienced an H3N2 infection earlier in life. This is an interesting phenomenon providing evidence for immune imprinting and a significant new insight which might be leveraged in future universal influenza virus vaccine strategies. Finally, preexisting immunity to pandemic H1 hemagglutinins was significantly associated with protection from infection in both children and adults. In adults, preexisting immunity to non-H1 group 1 hemagglutinins was also significantly associated with protection from infection.IMPORTANCE It is known since Thomas Francis, Jr. published his first paper on original antigenic sin in 1960 that the first infection(s) with influenza virus leaves a special immunological imprint which shapes immune responses to future infections with antigenically related influenza virus strains. Imprinting has been implicated in both protective effects as well as blunting of the immune response to vaccines. Despite the fact that this phenomenon was already described almost 60 years ago, we have very little detailed knowledge of the characteristics and breadth of the immune response to the first exposure(s) to influenza virus in life and how this compares to later exposure as adults. Here, we investigate these immune responses in detail using an influenza virus protein microarray. While our findings are mostly descriptive in nature and based on a small sample size, they provide a strong basis for future large-scale studies to better understand imprinting effects.
In contrast to influenza virus vaccination, natural infection induces long-lived and relatively broad immune responses. However, many aspects of the antibody response to natural infection are not well understood. Here, we assessed the immune response after H1N1 influenza virus infection in children and adults in a Nicaraguan household transmission study using an influenza virus protein microarray (IVPM). This technology allows us to simultaneously measure IgG and IgA antibody responses to hemagglutinins of many different virus strains and subtypes quantitatively with a high throughput. We found that children under 6 years of age responded to natural infection with a relatively narrow response that targeted mostly the hemagglutinin of the strain that caused the infection. Adults, however, have a much broader response, including a boost in antibodies to many group 1 subtype hemagglutinins. Also, a strong recall response against historic H1 hemagglutinins that share the K133 epitope with the pandemic H1N1 virus was observed. Of note, some children, while responding narrowly within H1 and group 1 hemagglutinins, induced a boost to H3 and other group 2 hemagglutinins when infected with H1N1 when they had experienced an H3N2 infection earlier in life. This is an interesting phenomenon providing evidence for immune imprinting and a significant new insight which might be leveraged in future universal influenza virus vaccine strategies. Finally, preexisting immunity to pandemic H1 hemagglutinins was significantly associated with protection from infection in both children and adults. In adults, preexisting immunity to non-H1 group 1 hemagglutinins was also significantly associated with protection from infection. It is known since Thomas Francis, Jr. published his first paper on original antigenic sin in 1960 that the first infection(s) with influenza virus leaves a special immunological imprint which shapes immune responses to future infections with antigenically related influenza virus strains. Imprinting has been implicated in both protective effects as well as blunting of the immune response to vaccines. Despite the fact that this phenomenon was already described almost 60 years ago, we have very little detailed knowledge of the characteristics and breadth of the immune response to the first exposure(s) to influenza virus in life and how this compares to later exposure as adults. Here, we investigate these immune responses in detail using an influenza virus protein microarray. While our findings are mostly descriptive in nature and based on a small sample size, they provide a strong basis for future large-scale studies to better understand imprinting effects.
It is known since Thomas Francis, Jr. published his first paper on original antigenic sin in 1960 that the first infection(s) with influenza virus leaves a special immunological imprint which shapes immune responses to future infections with antigenically related influenza virus strains. Imprinting has been implicated in both protective effects as well as blunting of the immune response to vaccines. Despite the fact that this phenomenon was already described almost 60 years ago, we have very little detailed knowledge of the characteristics and breadth of the immune response to the first exposure(s) to influenza virus in life and how this compares to later exposure as adults. Here, we investigate these immune responses in detail using an influenza virus protein microarray. While our findings are mostly descriptive in nature and based on a small sample size, they provide a strong basis for future large-scale studies to better understand imprinting effects. In contrast to influenza virus vaccination, natural infection induces long-lived and relatively broad immune responses. However, many aspects of the antibody response to natural infection are not well understood. Here, we assessed the immune response after H1N1 influenza virus infection in children and adults in a Nicaraguan household transmission study using an influenza virus protein microarray (IVPM). This technology allows us to simultaneously measure IgG and IgA antibody responses to hemagglutinins of many different virus strains and subtypes quantitatively with a high throughput. We found that children under 6 years of age responded to natural infection with a relatively narrow response that targeted mostly the hemagglutinin of the strain that caused the infection. Adults, however, have a much broader response, including a boost in antibodies to many group 1 subtype hemagglutinins. Also, a strong recall response against historic H1 hemagglutinins that share the K133 epitope with the pandemic H1N1 virus was observed. Of note, some children, while responding narrowly within H1 and group 1 hemagglutinins, induced a boost to H3 and other group 2 hemagglutinins when infected with H1N1 when they had experienced an H3N2 infection earlier in life. This is an interesting phenomenon providing evidence for immune imprinting and a significant new insight which might be leveraged in future universal influenza virus vaccine strategies. Finally, preexisting immunity to pandemic H1 hemagglutinins was significantly associated with protection from infection in both children and adults. In adults, preexisting immunity to non-H1 group 1 hemagglutinins was also significantly associated with protection from infection.
It is known since Thomas Francis, Jr. published his first paper on original antigenic sin in 1960 that the first infection(s) with influenza virus leaves a special immunological imprint which shapes immune responses to future infections with antigenically related influenza virus strains. Imprinting has been implicated in both protective effects as well as blunting of the immune response to vaccines. Despite the fact that this phenomenon was already described almost 60 years ago, we have very little detailed knowledge of the characteristics and breadth of the immune response to the first exposure(s) to influenza virus in life and how this compares to later exposure as adults. Here, we investigate these immune responses in detail using an influenza virus protein microarray. While our findings are mostly descriptive in nature and based on a small sample size, they provide a strong basis for future large-scale studies to better understand imprinting effects. In contrast to influenza virus vaccination, natural infection induces long-lived and relatively broad immune responses. However, many aspects of the antibody response to natural infection are not well understood. Here, we assessed the immune response after H1N1 influenza virus infection in children and adults in a Nicaraguan household transmission study using an influenza virus protein microarray (IVPM). This technology allows us to simultaneously measure IgG and IgA antibody responses to hemagglutinins of many different virus strains and subtypes quantitatively with a high throughput. We found that children under 6 years of age responded to natural infection with a relatively narrow response that targeted mostly the hemagglutinin of the strain that caused the infection. Adults, however, have a much broader response, including a boost in antibodies to many group 1 subtype hemagglutinins. Also, a strong recall response against historic H1 hemagglutinins that share the K133 epitope with the pandemic H1N1 virus was observed. Of note, some children, while responding narrowly within H1 and group 1 hemagglutinins, induced a boost to H3 and other group 2 hemagglutinins when infected with H1N1 when they had experienced an H3N2 infection earlier in life. This is an interesting phenomenon providing evidence for immune imprinting and a significant new insight which might be leveraged in future universal influenza virus vaccine strategies. Finally, preexisting immunity to pandemic H1 hemagglutinins was significantly associated with protection from infection in both children and adults. In adults, preexisting immunity to non-H1 group 1 hemagglutinins was also significantly associated with protection from infection. IMPORTANCE It is known since Thomas Francis, Jr. published his first paper on original antigenic sin in 1960 that the first infection(s) with influenza virus leaves a special immunological imprint which shapes immune responses to future infections with antigenically related influenza virus strains. Imprinting has been implicated in both protective effects as well as blunting of the immune response to vaccines. Despite the fact that this phenomenon was already described almost 60 years ago, we have very little detailed knowledge of the characteristics and breadth of the immune response to the first exposure(s) to influenza virus in life and how this compares to later exposure as adults. Here, we investigate these immune responses in detail using an influenza virus protein microarray. While our findings are mostly descriptive in nature and based on a small sample size, they provide a strong basis for future large-scale studies to better understand imprinting effects.
Author Meade, Philip
Krammer, Florian
Kirkpatrick, Ericka
Amanat, Fatima
Maier, Hannah E.
Javier, Andres
Strohmeier, Shirin
Nachbagauer, Raffael
Kuan, Guillermina
Gordon, Aubree
Gresh, Lionel
Balmaseda, Angel
Ito, Kimihito
Author_xml – sequence: 1
  givenname: Philip
  surname: Meade
  fullname: Meade, Philip
  organization: Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA, Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA, Centers of Excellence for Influenza Research and Surveillance (CEIRS), Center for Research on Influenza Pathogenesis (CRIP), New York, New York, USA
– sequence: 2
  givenname: Guillermina
  surname: Kuan
  fullname: Kuan, Guillermina
  organization: Sustainable Sciences Institute, Managua, Nicaragua, Centro de Salud Sócrates Flores Vivas, Ministry of Health, Managua, Nicaragua
– sequence: 3
  givenname: Shirin
  surname: Strohmeier
  fullname: Strohmeier, Shirin
  organization: Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA, Centers of Excellence for Influenza Research and Surveillance (CEIRS), Center for Research on Influenza Pathogenesis (CRIP), New York, New York, USA
– sequence: 4
  givenname: Hannah E.
  surname: Maier
  fullname: Maier, Hannah E.
  organization: Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, Michigan, USA
– sequence: 5
  givenname: Fatima
  surname: Amanat
  fullname: Amanat, Fatima
  organization: Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA, Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA, Centers of Excellence for Influenza Research and Surveillance (CEIRS), Center for Research on Influenza Pathogenesis (CRIP), New York, New York, USA
– sequence: 6
  givenname: Angel
  surname: Balmaseda
  fullname: Balmaseda, Angel
  organization: Centro de Salud Sócrates Flores Vivas, Ministry of Health, Managua, Nicaragua, Laboratorio Nacional de Virología, Centro Nacional de Diagnóstico y Referencia, Ministry of Health, Managua, Nicaragua
– sequence: 7
  givenname: Kimihito
  surname: Ito
  fullname: Ito, Kimihito
  organization: Division of Bioinformatics, Hokkaido University Research Center for Zoonosis Control, Kitaku, Japan
– sequence: 8
  givenname: Ericka
  surname: Kirkpatrick
  fullname: Kirkpatrick, Ericka
  organization: Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA, Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA, Centers of Excellence for Influenza Research and Surveillance (CEIRS), Center for Research on Influenza Pathogenesis (CRIP), New York, New York, USA
– sequence: 9
  givenname: Andres
  surname: Javier
  fullname: Javier, Andres
  organization: Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA
– sequence: 10
  givenname: Lionel
  surname: Gresh
  fullname: Gresh, Lionel
  organization: Centro de Salud Sócrates Flores Vivas, Ministry of Health, Managua, Nicaragua
– sequence: 11
  givenname: Raffael
  orcidid: 0000-0001-5568-5420
  surname: Nachbagauer
  fullname: Nachbagauer, Raffael
  organization: Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA, Centers of Excellence for Influenza Research and Surveillance (CEIRS), Center for Research on Influenza Pathogenesis (CRIP), New York, New York, USA
– sequence: 12
  givenname: Aubree
  surname: Gordon
  fullname: Gordon, Aubree
  organization: Centers of Excellence for Influenza Research and Surveillance (CEIRS), Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, Michigan, USA, St. Jude Center of Excellence for Influenza Research and Surveillance, Memphis, Tennessee, USA
– sequence: 13
  givenname: Florian
  orcidid: 0000-0003-4121-776X
  surname: Krammer
  fullname: Krammer, Florian
  organization: Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA, Centers of Excellence for Influenza Research and Surveillance (CEIRS), Center for Research on Influenza Pathogenesis (CRIP), New York, New York, USA
BackLink https://www.ncbi.nlm.nih.gov/pubmed/31964741$$D View this record in MEDLINE/PubMed
BookMark eNp1kstvEzEQxleoiJbSI1e0Ry5bPH7FviClEY9IFUgIuFpeP1pXjh3s3aLy1-M0pSJI-OKx_ZtvxvrmeXeUcnJd9xLQOQAWbzYXIZ8jgikZQD7pTjAwNCwYwNEu5jBgwPK4O6v1BrVFCAiCnnXHBCSnCwonXVonH2eXfun-eyhz7dvZmSnk1CI7G1d73X_SpeSf_TJNYcz2rv_i6jan6vqQ-tV1iLa41I_z1NCLkrVtgNExHnBLO8epvuieeh2rO3vYT7tv7999XX0cLj9_WK-Wl4NhIKfBA_dYUoqwA2xHQxlgg633I_hx5EAs9YJprEX7CYxUauCaOO0FAusJIqfdeq9rs75R2xI2utyprIO6v8jlSukyBROdEpJKxIRjnHCKMYjRSs4Q5gI5wTw0rbd7re08bpw1Lk1FxwPRw5cUrtVVvlVcLihbsCbw-kGg5B-zq5PahGpcjDq5PFeFCSWsmSN2fb_6u9ZjkT-GNWDYA6bkWovzjwggtZsJtZsJdT8TCmTjyT-8CZPe-dtaDfE_Wb8BtNS6JQ
CitedBy_id crossref_primary_10_1371_journal_ppat_1008583
crossref_primary_10_1038_s41467_024_47455_6
crossref_primary_10_1038_s41579_023_00945_8
crossref_primary_10_1038_s41586_020_2711_0
crossref_primary_10_1542_peds_2020_019901
crossref_primary_10_1093_infdis_jiae258
crossref_primary_10_1016_j_bioorg_2023_106712
crossref_primary_10_3390_vaccines11030593
crossref_primary_10_1038_s41467_021_23977_1
crossref_primary_10_1542_peds_2021_052173
crossref_primary_10_1016_j_chom_2024_06_015
crossref_primary_10_1128_mBio_02808_20
crossref_primary_10_1038_s41467_020_17488_8
crossref_primary_10_3390_v14112587
crossref_primary_10_7554_eLife_81457
crossref_primary_10_3389_fimmu_2020_610688
crossref_primary_10_3389_fimmu_2020_02057
crossref_primary_10_3390_vaccines11071241
crossref_primary_10_1128_jvi_00109_25
crossref_primary_10_1038_s41591_022_01690_w
crossref_primary_10_1007_s11071_022_07661_7
crossref_primary_10_1038_s41590_021_01089_8
crossref_primary_10_1186_s12879_021_06988_7
crossref_primary_10_1080_09712119_2022_2133902
crossref_primary_10_3390_v13061109
crossref_primary_10_3389_fimmu_2022_987984
crossref_primary_10_1093_infdis_jiad029
crossref_primary_10_1016_j_vaccine_2021_05_064
crossref_primary_10_3390_v16050801
crossref_primary_10_1007_s44307_025_00057_9
crossref_primary_10_1128_jvi_01070_22
crossref_primary_10_3390_v13020278
crossref_primary_10_1038_s41467_020_16545_6
crossref_primary_10_3390_microbiolres12030044
crossref_primary_10_3390_vaccines9090979
crossref_primary_10_1038_s41467_024_47590_0
crossref_primary_10_3390_v13060965
crossref_primary_10_1038_s41541_022_00490_0
crossref_primary_10_1038_s41590_021_01122_w
crossref_primary_10_3389_fimmu_2020_607333
crossref_primary_10_1038_s41590_021_01123_9
crossref_primary_10_3390_v13040619
crossref_primary_10_1038_s41590_021_01085_y
crossref_primary_10_3390_v13071400
crossref_primary_10_1093_infdis_jiae122
crossref_primary_10_1172_JCI150613
crossref_primary_10_1126_science_abd4570
crossref_primary_10_3390_bios15030198
crossref_primary_10_1093_cid_ciac734
Cites_doi 10.1084/jem.20130212
10.1038/emi.2017.98
10.1016/j.cell.2018.03.030
10.1016/j.chom.2019.01.002
10.1038/nature06890
10.1016/j.coviro.2016.12.004
10.1016/j.coviro.2014.07.007
10.1038/ncomms8708
10.1371/journal.pone.0043603
10.1006/viro.2000.0453
10.1128/JVI.03099-14
10.1126/science.1205669
10.1007/s11684-017-0602-z
10.1038/nm.4224
10.3791/51112
10.1016/j.chom.2016.05.014
10.1128/JVI.00169-19
10.1073/pnas.1409171111
10.1038/s41591-019-0463-x
10.1084/jem.20101352
10.1126/science.1256427
10.1126/science.1222908
10.3201/eid2410.161258
10.1056/NEJMoa0903810
10.1038/ni.3680
10.1016/j.coi.2018.05.010
10.3390/vaccines6020028
10.1038/ni.3684
10.1016/j.vaccine.2017.08.044
10.1371/journal.ppat.1002802
10.1038/s41577-019-0143-6
10.1126/science.aag1322
10.1016/j.vaccine.2018.04.063
10.1128/mBio.01996-15
10.1126/sciimmunol.aan2676
10.1126/scitranslmed.3006637
ContentType Journal Article
Copyright Copyright © 2020 Meade et al.
Copyright © 2020 Meade et al. 2020 Meade et al.
Copyright_xml – notice: Copyright © 2020 Meade et al.
– notice: Copyright © 2020 Meade et al. 2020 Meade et al.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOA
DOI 10.1128/mBio.03243-19
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic
MEDLINE

CrossRef
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
DocumentTitleAlternate Influenza Virus Antibodies in Infected Patients
EISSN 2150-7511
ExternalDocumentID oai_doaj_org_article_8949058e563642218bd96502680e85f1
PMC6974575
31964741
10_1128_mBio_03243_19
Genre Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NIAID NIH HHS
  grantid: HHSN272201400008C
– fundername: NIAID NIH HHS
  grantid: P01 AI097092
– fundername: NIAID NIH HHS
  grantid: R01 AI120997
– fundername: NIAID NIH HHS
  grantid: T32 AI007647
– fundername: NIAID NIH HHS
  grantid: HHSN272201400006C
– fundername: ;
  grantid: HHSN272201400008C
– fundername: ;
  grantid: HHSN272201400006C
– fundername: ;
  grantid: AI120997
GroupedDBID ---
0R~
53G
5VS
AAFWJ
AAGFI
AAUOK
AAYXX
ADBBV
AENEX
AFPKN
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BCNDV
BTFSW
CITATION
DIK
E3Z
EBS
FRP
GROUPED_DOAJ
GX1
H13
HYE
HZ~
KQ8
M48
O5R
O5S
O9-
OK1
P2P
PGMZT
RHI
RNS
RPM
RSF
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
ID FETCH-LOGICAL-c519t-f16f294402e12dbc4512c2dffb1fbb613d4f85a2a83191b49a16a3eaf801df303
IEDL.DBID M48
ISSN 2161-2129
2150-7511
IngestDate Wed Aug 27 01:32:09 EDT 2025
Thu Aug 21 13:41:37 EDT 2025
Fri Jul 11 08:26:46 EDT 2025
Mon Jul 21 05:38:58 EDT 2025
Thu Apr 24 23:05:39 EDT 2025
Tue Jul 01 01:52:42 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords influenza
influenza virus
cross-reactivity
natural infection
imprinting
heterosubtypic immunity
Language English
License Copyright © 2020 Meade et al.
This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c519t-f16f294402e12dbc4512c2dffb1fbb613d4f85a2a83191b49a16a3eaf801df303
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0003-4121-776X
0000-0001-5568-5420
OpenAccessLink https://doaj.org/article/8949058e563642218bd96502680e85f1
PMID 31964741
PQID 2343503380
PQPubID 23479
ParticipantIDs doaj_primary_oai_doaj_org_article_8949058e563642218bd96502680e85f1
pubmedcentral_primary_oai_pubmedcentral_nih_gov_6974575
proquest_miscellaneous_2343503380
pubmed_primary_31964741
crossref_primary_10_1128_mBio_03243_19
crossref_citationtrail_10_1128_mBio_03243_19
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 20200121
PublicationDateYYYYMMDD 2020-01-21
PublicationDate_xml – month: 1
  year: 2020
  text: 20200121
  day: 21
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: 1752 N St., N.W., Washington, DC
PublicationTitle mBio
PublicationTitleAlternate mBio
PublicationYear 2020
Publisher American Society for Microbiology
Publisher_xml – name: American Society for Microbiology
References e_1_3_2_26_2
e_1_3_2_27_2
e_1_3_2_28_2
e_1_3_2_29_2
e_1_3_2_20_2
e_1_3_2_21_2
e_1_3_2_22_2
e_1_3_2_23_2
e_1_3_2_24_2
e_1_3_2_25_2
e_1_3_2_9_2
e_1_3_2_15_2
e_1_3_2_38_2
e_1_3_2_8_2
e_1_3_2_16_2
e_1_3_2_37_2
e_1_3_2_7_2
e_1_3_2_17_2
e_1_3_2_6_2
e_1_3_2_18_2
e_1_3_2_19_2
e_1_3_2_30_2
e_1_3_2_32_2
e_1_3_2_10_2
e_1_3_2_31_2
e_1_3_2_5_2
e_1_3_2_11_2
e_1_3_2_34_2
e_1_3_2_12_2
e_1_3_2_33_2
e_1_3_2_3_2
Francis T (e_1_3_2_4_2) 1960; 104
e_1_3_2_13_2
e_1_3_2_36_2
e_1_3_2_2_2
e_1_3_2_14_2
e_1_3_2_35_2
References_xml – ident: e_1_3_2_11_2
  doi: 10.1084/jem.20130212
– ident: e_1_3_2_14_2
  doi: 10.1038/emi.2017.98
– ident: e_1_3_2_18_2
  doi: 10.1016/j.cell.2018.03.030
– ident: e_1_3_2_26_2
  doi: 10.1016/j.chom.2019.01.002
– ident: e_1_3_2_17_2
  doi: 10.1038/nature06890
– ident: e_1_3_2_10_2
  doi: 10.1016/j.coviro.2016.12.004
– ident: e_1_3_2_9_2
  doi: 10.1016/j.coviro.2014.07.007
– ident: e_1_3_2_31_2
  doi: 10.1038/ncomms8708
– ident: e_1_3_2_37_2
  doi: 10.1371/journal.pone.0043603
– ident: e_1_3_2_24_2
  doi: 10.1006/viro.2000.0453
– ident: e_1_3_2_19_2
  doi: 10.1128/JVI.03099-14
– ident: e_1_3_2_30_2
  doi: 10.1126/science.1205669
– ident: e_1_3_2_33_2
  doi: 10.1007/s11684-017-0602-z
– ident: e_1_3_2_35_2
  doi: 10.1038/nm.4224
– ident: e_1_3_2_36_2
  doi: 10.3791/51112
– ident: e_1_3_2_34_2
  doi: 10.1016/j.chom.2016.05.014
– ident: e_1_3_2_8_2
  doi: 10.1128/JVI.00169-19
– ident: e_1_3_2_12_2
  doi: 10.1073/pnas.1409171111
– ident: e_1_3_2_3_2
  doi: 10.1038/s41591-019-0463-x
– ident: e_1_3_2_38_2
  doi: 10.1084/jem.20101352
– ident: e_1_3_2_27_2
  doi: 10.1126/science.1256427
– ident: e_1_3_2_29_2
  doi: 10.1126/science.1222908
– volume: 104
  start-page: 572
  year: 1960
  ident: e_1_3_2_4_2
  article-title: On the doctrine of original antigenic sin
  publication-title: Proc Am Philos Soc
– ident: e_1_3_2_15_2
  doi: 10.3201/eid2410.161258
– ident: e_1_3_2_16_2
  doi: 10.1056/NEJMoa0903810
– ident: e_1_3_2_21_2
  doi: 10.1038/ni.3680
– ident: e_1_3_2_5_2
  doi: 10.1016/j.coi.2018.05.010
– ident: e_1_3_2_6_2
  doi: 10.3390/vaccines6020028
– ident: e_1_3_2_13_2
  doi: 10.1038/ni.3684
– ident: e_1_3_2_25_2
  doi: 10.1016/j.vaccine.2017.08.044
– ident: e_1_3_2_28_2
  doi: 10.1371/journal.ppat.1002802
– ident: e_1_3_2_2_2
  doi: 10.1038/s41577-019-0143-6
– ident: e_1_3_2_7_2
  doi: 10.1126/science.aag1322
– ident: e_1_3_2_20_2
  doi: 10.1016/j.vaccine.2018.04.063
– ident: e_1_3_2_22_2
  doi: 10.1128/mBio.01996-15
– ident: e_1_3_2_32_2
  doi: 10.1126/sciimmunol.aan2676
– ident: e_1_3_2_23_2
  doi: 10.1126/scitranslmed.3006637
SSID ssj0000331830
Score 2.4525728
Snippet It is known since Thomas Francis, Jr. published his first paper on original antigenic sin in 1960 that the first infection(s) with influenza virus leaves a...
In contrast to influenza virus vaccination, natural infection induces long-lived and relatively broad immune responses. However, many aspects of the antibody...
ABSTRACT In contrast to influenza virus vaccination, natural infection induces long-lived and relatively broad immune responses. However, many aspects of the...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
SubjectTerms Adult
Age Factors
Animals
Antibodies, Viral - immunology
Antigens, Viral - immunology
Child
Clinical Science and Epidemiology
Cross Reactions
cross-reactivity
Editor's Pick
heterosubtypic immunity
Humans
Immunoglobulin A - immunology
Immunoglobulin G - immunology
Immunologic Memory
imprinting
influenza
Influenza Vaccines - immunology
influenza virus
Influenza, Human - epidemiology
Influenza, Human - immunology
Influenza, Human - virology
Mice
natural infection
Orthomyxoviridae - classification
Orthomyxoviridae - immunology
Phylogeny
Vaccination
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1NS8QwEA0iCF7Eb9cvIogno03aZtPjKooKehAVbyFpEixoVna7B_31TtLusiuKF6_t0KaZSd4bMn2D0KHguS65oSTV1pLMqYJol6ZEaGqNUkrQKNd0e8evHrOb5_x5qtVXqAlr5IGbiTsVRVYkubA5T4EqAyBpUwCrYFwkVuQuJj6AeVPJVNyD0xCryVhUk4nTt7Oqf5IAfUhJUNWZAqGo1f8TwfxeJzkFPJfLaKlljLjXjHQFzVm_ihaaHpIfa8hfN21GPhV-qgajIb5uy6s8Dm05YBvACt9FqUXc83Wl--YD3zeVsRZXHp-3v3NjParBFPJyZcAAfPc6Y9cLSh3DdfR4efFwfkXaJgqkBHJWE0e5Y0UGaaKlzOgyA4QvmXFOU6c1gLnJnMgVUwIWI9VZoShXqVUOoMs4ALgNNO_73m4hzLvGFLrs2iiEZoVmgsLzyoxrnrgy6aDj8azKslUYD40uXmXMNJiQwQkyOkHSooOOJubvjbTGb4ZnwUUTo6CIHS9AnMg2TuRfcdJBB2MHS1hB4VhEedsfDSVLgTJCwAj4gM3G4ZNXRb0yIF0d1J0JhZmxzN7x1UtU6eaQqQEX3v6Pwe-gRRby_IQSRnfRfD0Y2T0gQ7Xej3H_BfIIBk4
  priority: 102
  providerName: Directory of Open Access Journals
Title Influenza Virus Infection Induces a Narrow Antibody Response in Children but a Broad Recall Response in Adults
URI https://www.ncbi.nlm.nih.gov/pubmed/31964741
https://www.proquest.com/docview/2343503380
https://pubmed.ncbi.nlm.nih.gov/PMC6974575
https://doaj.org/article/8949058e563642218bd96502680e85f1
Volume 11
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3fb9MwELbQEBIvaPwujMlIiCc8Yidx7QeEuomxIW0PiKK-WXZsQ6TijDaV1v31OztpIdOQeMlDcnJi353vO8f-DqE3gpem4paS3DhHCq8lMT7PiTDUWa21oImu6eycn0yLL7Ny9odSqB_A5a2pXawnNV3MDy5_rz-Cw3_oDsCI978O6-YgA2SQk0gAeheC0jj66FmP9NOknEfjjSsuDDAOgQlbbhg3b7YwiFCJyP829HlzE-VfUel4Fz3o4SSedPp_iO648Ajd6wpMrh-jcNrVILnS-Hu9WC3xab_3KuBYswPmCKzxeeJhxJPQ1qaxa_y12zbrcB3wUX_WG5tVC6KQtGsLAqDY-UBuEmk8lk_Q9PjTt6MT0ldYIBUgt5Z4yj2TBeSQjjJrqgLCf8Ws94Z6YyDS28KLUjMtwFOpKaSmXOdOe4hr1kP0e4p2QhPcc4T52FppqrFLLGlOGCYotFcV3PDMV9kIvduMqqp6-vFYBWOuUhrChIpKUEkJisoRersVv-h4N_4leBhVtBWKdNnpRrP4oXrvU0IWMiuFK3kO-RagGmMlQFPGReZE6ekIvd4oWIF7xX8mOrhmtVQsBzwJxiOgA886hW9flcjMAJGN0HhgCoNvGT4J9c9E4c0hjQOg_OJ_e_kS3Wcx0c-i6e6hnXaxcq8ADbVmP60iwPXzjO4nm78GFoYJlg
linkProvider Scholars Portal
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Influenza+Virus+Infection+Induces+a+Narrow+Antibody+Response+in+Children+but+a+Broad+Recall+Response+in+Adults&rft.jtitle=mBio&rft.au=Meade%2C+Philip&rft.au=Kuan%2C+Guillermina&rft.au=Strohmeier%2C+Shirin&rft.au=Maier%2C+Hannah+E.&rft.date=2020-01-21&rft.issn=2161-2129&rft.eissn=2150-7511&rft.volume=11&rft.issue=1&rft_id=info:doi/10.1128%2FmBio.03243-19&rft.externalDBID=n%2Fa&rft.externalDocID=10_1128_mBio_03243_19
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2161-2129&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2161-2129&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2161-2129&client=summon